Audax, Linden-owned StatLab acquires Pyramid Innovation

Diagnostic equipment maker StatLab Medical Products acquires a pathology laboratory instrument developer.

Diagnostic equipment developer StatLab Medical Products, backed by Linden Capital Partners and Audax Private Equity, has acquired pathology instrument developer Pyramid Innovation. The partnership broadens StatLab’s instrument manufacturing capabilities.

PRESS RELEASE

StatLab Medical Products (“StatLab”), a leading developer and manufacturer of diagnostic supplies and equipment for the anatomic pathology market, has acquired Pyramid Innovation (“Pyramid”). The acquisition broadens StatLab’s instrument manufacturing capabilities by adding slide and cassette printers. StatLab is a portfolio company of Linden Capital Partners and Audax Private Equity.

Pyramid Innovation was founded in 2013 by Tom Hughes and is based in Sussex, England. Prior to founding Pyramid, Tom and his team developed the first ever automated pathology slide and cassette printers. Today, Pyramid Innovation is a global leader in developing instrumentation that improves the efficiency of pathology laboratory workflow.

“We are excited to welcome Pyramid Innovation into the StatLab family” said Mike Karsonovich, CEO of StatLab. “Partnering with Pyramid positions StatLab as a direct source of high-quality laboratory automation equipment for our U.S. customer base, in addition to expanding our reach into the international market through established channel partners.”

Tom Hughes, Managing Director of Pyramid, adds, “StatLab is an ideal fit as a partner for continued innovation in the field. We are anticipating success with sales of our newly-launched PiSmart Cassette printers and look forward to continued investment in the product pipeline – we have more exciting innovations in development to further benefit our customers around the world.”

Pyramid operations will remain in Sussex and continue to be led by Mr. Hughes.

About StatLab Medical Products
Founded in 1976, StatLab Medical Products is leading the way in development and manufacturing of high-quality histology, cytology and immunohistochemistry diagnostic products. We partner with anatomic pathology laboratories to provide easy access to over 3,500 high-quality diagnostic products and equipment at excellent prices, delivered with expert support. When you work with StatLab, we’re on your team, and you’re part of our family. Learn more at www.statlab.com.

About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the country’s largest dedicated healthcare private equity firms. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating experience, and (iii) its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested more than $2.5 billion in healthcare companies. For more information, please visit www.lindenllc.com.

About Audax Private Equity
Audax Group is a leading alternative investment manager with offices in Boston, New York, and San Francisco. Since its founding in 1999, the firm has raised over $30 billion in capital across its Private Equity and Private Debt businesses. Audax Private Equity has invested over $7 billion in more than 140 platforms and over 975 add-on companies, and is currently investing out of its $3.5 billion, sixth private equity fund. Through its disciplined Buy & Build approach, Audax Private Equity seeks to help platform companies execute add-on acquisitions that fuel revenue growth, optimize operations, and significantly increase equity value. With more than 250 employees, Audax is a leading capital partner for North American middle market companies. For more information, visit the Audax Private Equity website: www.audaxprivateequity.com or follow Audax on LinkedIn.